Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [11] The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis
    Tan, Ping
    Wei, Shiyou
    Yang, Lu
    Tang, Zhuang
    Cao, Dehong
    Liu, Liangren
    Lei, Junhao
    Fan, Yu
    Gao, Liang
    Wei, Qiang
    SCIENTIFIC REPORTS, 2016, 6
  • [12] Imaging of Prostate Specific Membrane Antigen Targeted Radiotracers for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
    Tan, Nelly
    Bavadian, Niusha
    Calais, Jeremie
    Oyoyo, Udochukwu
    Kim, Johnathan
    Turkbey, I. Baris
    Mena, Esther
    Davenport, Matthew S.
    JOURNAL OF UROLOGY, 2019, 202 (02): : 231 - 240
  • [13] Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer
    McKay, Rana R.
    Gray, Kathryn P.
    Hayes, Julia H.
    Bubley, Glenn J.
    Rosenberg, Jonathan E.
    Hussain, Arif
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    CANCER, 2015, 121 (15) : 2603 - 2611
  • [14] Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis
    Matsukawa, Akihiro
    Yanagisawa, Takafumi
    Fazekas, Tamas
    Miszczyk, Marcin
    Tsuboi, Ichiro
    Kardoust Parizi, Mehdi
    Laukhtina, Ekaterina
    Klemm, Jakob
    Mancon, Stefano
    Mori, Keiichiro
    Kimura, Shoji
    Miki, Jun
    Gomez Rivas, Juan
    Soeterik, Timo F. W.
    Zilli, Thomas
    Tilki, Derya
    Joniau, Steven
    Kimura, Takahiro
    Shariat, Shahrokh F.
    Rajwa, Pawel
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [15] Biochemical recurrence after definitive prostate cancer therapy. Part I: Defining and localizing biochemical recurrence of prostate cancer
    Ward, JF
    Moul, JW
    CURRENT OPINION IN UROLOGY, 2005, 15 (03) : 181 - 186
  • [16] Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis
    Meng, Yang
    Liao, Yan-Biao
    Xu, Peng
    Wei, Wu-Ran
    Wang, Jia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 13267 - 13274
  • [17] Vasectomy and the risk of prostate cancer: a meta-analysis of cohort studies
    Zhang, Xiao-Long
    Yan, Jia-Jun
    Pan, Shou-Hua
    Pan, Jian-Gang
    Ying, Xiang-Rong
    Zhang, Guan-Fu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 17977 - +
  • [18] Vasectomy and prostate cancer risk: a meta-analysis of cohort studies
    Shang, Yonggang
    Han, Guangwei
    Li, Jia
    Zhao, Jiang
    Cui, Dong
    Liu, Chengcheng
    Yi, Shanhong
    SCIENTIFIC REPORTS, 2015, 5
  • [19] Vasectomy and prostate cancer risk: a meta-analysis of cohort studies
    Yonggang Shang
    Guangwei Han
    Jia Li
    Jiang Zhao
    Dong Cui
    Chengcheng Liu
    Shanhong Yi
    Scientific Reports, 5
  • [20] Association of statin use with risk of dementia: A meta-analysis of prospective cohort studies
    Song, Yu
    Nie, Hongwei
    Xu, Yong
    Zhang, Ling
    Wu, Yan
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2013, 13 (04) : 817 - 824